Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)
This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Terrie Curran Director |
SELL
Open market or private sale
|
Direct |
8,687
-46.14%
|
$86,870
$10.85 P/Share
|
|
Nov 04
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
15,441
-7.92%
|
$123,528
$8.68 P/Share
|
|
Nov 04
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
13,871
-1.64%
|
$110,968
$8.68 P/Share
|
|
Nov 04
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,015
-2.74%
|
$40,120
$8.68 P/Share
|
|
Nov 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.5%
|
$80,000
$8.65 P/Share
|
|
Oct 02
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,725
-2.65%
|
$37,250
$10.01 P/Share
|
|
Oct 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.21%
|
$90,000
$9.26 P/Share
|
|
Sep 24
2024
|
David Joseph Topper Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,626
-6.84%
|
$104,634
$9.48 P/Share
|
|
Sep 21
2024
|
David Joseph Topper Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+26.09%
|
-
|
|
Sep 03
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-4.95%
|
$100,000
$10.77 P/Share
|
|
Aug 19
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
1,728
-0.88%
|
$13,824
$8.29 P/Share
|
|
Aug 02
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
14,487
-1.68%
|
$130,383
$9.02 P/Share
|
|
Aug 02
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
13,206
-6.29%
|
$118,854
$9.02 P/Share
|
|
Aug 02
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,220
-2.77%
|
$46,980
$9.02 P/Share
|
|
Aug 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.71%
|
$90,000
$9.87 P/Share
|
|
Aug 01
2024
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,614
+3.42%
|
$6,614
$1.68 P/Share
|
|
Jul 01
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.25%
|
$90,000
$9.31 P/Share
|
|
Jul 01
2024
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.59%
|
$10,000
$1.68 P/Share
|
|
Jun 14
2024
|
Bhaskar Chaudhuri Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+1.16%
|
-
|
|
Jun 14
2024
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Sue Jean Lin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+34.65%
|
-
|
|
Jun 14
2024
|
Neha Krishnamohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+39.17%
|
-
|
|
Jun 14
2024
|
Terrie Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Patrick J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Howard G. Welgus Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+5.32%
|
-
|
|
Jun 14
2024
|
Keith R Leonard Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 04
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.81%
|
$80,000
$8.01 P/Share
|
|
Jun 04
2024
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.73%
|
$10,000
$1.68 P/Share
|
|
May 30
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
23,000
-9.88%
|
$184,000
$8.75 P/Share
|
|
May 30
2024
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+8.99%
|
-
|
|
May 29
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
49,952
-19.23%
|
$399,616
$8.72 P/Share
|
|
May 28
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,775
-0.93%
|
$15,975
$9.01 P/Share
|
|
May 27
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+2.5%
|
-
|
|
May 17
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,640
-5.16%
|
$61,120
$8.98 P/Share
|
|
May 16
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+28.85%
|
-
|
|
May 02
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,681
-3.12%
|
$37,448
$8.74 P/Share
|
|
May 02
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
9,555
-3.55%
|
$76,440
$8.74 P/Share
|
|
May 02
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,016
-2.63%
|
$40,128
$8.74 P/Share
|
|
May 02
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
13,783
-1.58%
|
$110,264
$8.74 P/Share
|
|
May 01
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,166
+2.7%
|
-
|
|
Apr 10
2024
|
David Joseph Topper Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+50.0%
|
-
|
|
Mar 04
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
3,760
-1.94%
|
$41,360
$11.12 P/Share
|
|
Mar 04
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
14,903
-1.68%
|
$163,933
$11.12 P/Share
|
|
Mar 04
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
4,782
-1.74%
|
$52,602
$11.12 P/Share
|
|
Mar 04
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,468
-2.32%
|
$38,148
$11.12 P/Share
|
|
Mar 04
2024
|
Patrick J Heron Director |
BUY
Open market or private purchase
|
Indirect |
21,052
+0.24%
|
$189,468
$9.5 P/Share
|
|
Feb 28
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,465
-0.28%
|
$24,650
$10.6 P/Share
|
|
Feb 13
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,898
+14.3%
|
-
|
|
Feb 13
2024
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,050
+14.91%
|
-
|
|
Feb 13
2024
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
264,882
+7.55%
|
-
|